Inhibitors of acyl-CoA:cholesterol acyltransferase: Novel trisubstituted ureas as hypocholesterolemic agents

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 4, 1997, Pages 739-747

  Purchase, Terri S ^a   Essenburg, Arnold D ^a   Hamelehle, Katherine L ^a   Hes, MaryKay S ^a   Holmes, Ann ^a   Krause, Brian R ^a   Stanfield, Richard L ^a   Trivedi, Bharat K ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DIFLUOROPHENYL) 1 HEPTYL 1 (4 NEOPENTYLBENZYL)UREA; ANTILIPEMIC AGENT; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; UREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; BENZENE DERIVATIVES; CHOLESTEROL; DIET; DISEASE MODELS, ANIMAL; FLUORIDES; HYPERCHOLESTEROLEMIA; MAGNETIC RESONANCE SPECTROSCOPY; RABBITS; RATS; STEROL O-ACYLTRANSFERASE; STRUCTURE-ACTIVITY RELATIONSHIP; UREA;

ANIMALIA; ORYCTOLAGUS CUNICULUS; TRIFLUORO;

EID: 0030915341     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(97)00019-9     Document Type: Article

References (24)

1. Stoeber, T. L.; Holmes, A.; Essenburg, A. D.; Hamelehle, K. L.; Shaw, M. K.; Stanfield, R. L.; Krause, B. R.; Trivedi, B. K. Abstracts of Papers, 201st National Meeting, American Chemical Society: Atlanta, Georgia, 1991; MEDI-113.
2. (a) Norum, K. R.; Lillijeqvist, A.-C.; Helgerud, P.; Normann, E. R.; Mo, A.; Selbekk, B. Eur. J. Clin. Invest. 1979, 9, 55.
3. (b) Suckling, K. E.; Stange, E. F. J. Lipid Res. 1985, 26, 647.
4. (a) Cianflone, K. M.; Yasruel, Z.; Rodriguez, M. A.; Vas, D.; Sniderman, A. D. J. Lipid Res. 1990, 31, 2045.
5. (b) Dashti, N. J. Biol. Chem. 1992, 267, 7160.
6. (c) Carr, T. P.; Parks, J. S.; Rudel, L. L. Arterio. Thrombo. 1992, 12, 1274.
7. (d) Tanaka, M.; Jingami, H.; Otani, H.; Cho, M.; Ueda, Y.; Arai, H.; Nagano, Y.; Doi, T.; Yokode, M.; Kita, T. J. Biol. Chem. 1993, 268, 12713.
8. (a) Bocan, T. M. A.; Bak Mueller, S.; Uhlendorf, P. D.; Newton, R. S.; Krause, B. R. Arterio. Thrombo. 1991, 11, 1830.
9. (b) Bocan, T. M. A.; Bak Mueller, S.; Uhlendorf, P. D.; Brown, E. Q.; Mazur, M. J.; Black, H. E. Atherosclerosis 1993, 99, 175.
10. Roth, B. D.; Blankley, C. J.; Hoefle, M. L.; Holmes, A.; Roark, W. H.; Trivedi, B. K.; Essenburg, A. D.; Kieft, K. A.; Krause, B. R.; Stanfield, R. L. J. Med. Chem. 1992, 35, 1609.
11. Trivedi, B. K.; Holmes, A.; Stoeber, T. L.; Blankley, C. J.; Roark, W. H.; Picard, J. A.; Shaw, M. K.; Essenburg, A. D.; Stanfield, R. L.; Krause, B. R. J. Med. Chem. 1993, 36, 3300.
12. Krause, B. R.; Black, A.; Bousley, R. F.; Essenburg, A. D.; Cornicelli, J. A.; Holmes, A.; Homan, R.; Kieft, K. A.; Sekerke, C.; Shaw, M. K.; Stanfield, R. L.; Trivedi, B. K.; Woolf, T. J. Pharmacol. Exp. Ther. 1993, 267, 734.
13. Trivedi, B. K.; Purchase, T. S.; Holmes, A.; Augelli-Szafran, C. E.; Essenburg, A. D.; Hamelehle, K. L.; Stanfield, R. L.; Bousley, R. F.; Krause, B. R. J. Med. Chem. 1994, 37, 1652.
14. Sliskovic, D. R.; Trivedi, B. K. Curr. Med. Chem. 1994, 1, 204.
15. (a) DeVries, V. G.; Schaffer, S. A.; Largis, E. E.; Dutia, M. D.; Wang, C-H.; Bloom, J. D.; Katocs, Jr. A. S. J. Med. Chem. 1986, 29, 1131.
16. (b) Largis, E. E.; Wang, C.-H.; DeVries, V. G.; Schaffer, S. A. J. Lipid Res. 1989, 30, 681.
17. (c) DeVries, V. G.; Bloom, J. D.; Dutia, M. D.; Katocs, Jr. A. S.; Largis, E. E. J. Med. Chem. 1989, 32, 2318.
18. (d) Balasubramaniam, S.; Simons, L. A.; Chang, S.; Roach, P. D.; Nestel, P. J. Atherosclerosis 1990, 82, 1.
19. (e) Katocs, Jr. A. S.; Wang, C.-H.; Largis, E. E. FASEB J 1988, 2, 5365.
20. Matsuda, K. Med. Res. Rev. 1994, 14, 271.
21. Butler, D. E.; Pollatz, J. C. J. Org. Chem. 1971, 36, 1308.
22. Belgian Patent No. BE 900178-A, 1983 (U. K. Patent No. GB 2149 394 A).
23. CLOGPs calculated using CLOCP3 v2.1 (Biobyte Corp.).
24. Krause, B. R.; Bocan, T. M. A. In Inflammation Mediators and Pathways; Ruffolo, Jr. R. R.; Hollinger, M. A., Eds.; CRC: Boca Raton, 1995; pp 173-198.